ArticleLeukemia2015

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.

Anna M Eiring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.